Please login to the form below

Not currently logged in
Email:
Password:

EY appoints global life sciences industry leader

Pamela Spence brings nearly 20 years of life sciences expertise to the role

EY Pamela SpenceEY has appointed Pamela Spence as industry leader for its global life sciences practice.

Spence has nearly 20 years of experience working with clients across the life sciences and healthcare sectors, most recently having served as global lead partner for a number of EY's international life sciences clients.

She first joined EY in 1998 and has since held increasingly senior leadership positions in its transaction advisory services within the health and technology sectors.

In her new role, Spence will continue to serve on the EU global accounts committee, which oversees the strategic direction of all the company's industry sectors.

She said: “Around the world, companies in the sector are looking to transform and innovate their strategies as they adapt to various health care reforms and the evolving industry landscape.

“New solutions will be required to meet the global challenges of sustainability of healthcare systems, aging populations, chronic disease and increasing cost pressures.

“I look forward to working with our team of dedicated professionals to help our clients respond to these and other challenges.” 

29th July 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

R&D protocol amendments
Rethinking trials: the pros and cons of protocol amendments
Protocol amendments occur often and can be beneficial, but the steps involved can be complex...
Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...

Infographics